Ophthalmic delivery of cyclosporine A by punctal plugs

Journal of Controlled Release

Volumn 150, Issue 1, 2011, Pages 70-76

  Gupta, Chhavi ^a   Chauhan, Anuj ^a  

^a University of Florida   (United States)

Author keywords

Cyclosporine A; Dry eyes; Extended release; HEMA; Mechanisms; Ocular pharmacokinetic model; Ophthalmic drug delivery; Punctal plugs

Indexed keywords

CYCLOSPORINE A; DRY EYES; EXTENDED RELEASE; HEMA; OCULAR PHARMACOKINETIC MODEL; OPHTHALMIC DRUG DELIVERY; PUNCTAL PLUGS;

DRUG DELIVERY; EMULSIFICATION; MATHEMATICAL MODELS; SILICONES;

PHARMACOKINETICS;

2 HYDROXYETHYL METHACRYLATE; CYCLOSPORIN A; SILICON;

ARTICLE; DRUG RELEASE; DRY EYE; HUMAN; MATHEMATICAL MODEL; PRIORITY JOURNAL;

CYCLOSPORINE; DELAYED-ACTION PREPARATIONS; DRY EYE SYNDROMES; EYE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHACRYLATES; MODELS, BIOLOGICAL; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN;

EID: 79951956707     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.11.009     Document Type: Article

References (39)

1. M. Doughty, D. Fonn, D. Richter, T. Simpson, B. Caffery, K. Gordon, A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada, Optom. Vis. Sci. 74 (1997) 624-631. (Pubitemid 27432771)
2. C. McMonnies, A. Ho, Marginal dry eye diagnosis: history versus biomicroscopy, in: F.J. Holly (Ed.), The preocular tear film in health, disease, and contact lens wear, Dry Eye Institute, Lubbuck, TX, 1986, pp. 32-40.
3. C. Begley, R. Chalmers, G.E.A. Mitchell, Characterization of ocular surface symptoms from optometric practices in North America, Cornea 20 (2001) 610-618. (Pubitemid 32706197)
4. M. Guzey, A. Satici, S. Korhan, K. Sezgin, S. Bozkurt, The effect of lubricating eye drop containing hydroxypropyl guar on perimetry results of patients with glaucoma and trachomatous dry eye, Ophthalmologica 224 (2010) 109-115.
5. H. Zhu, A. Chauhan, A mathematical model for ocular and tear solute balance, Curr. Eye Res. 30 (2005) 841-854.
6. J. Berger, K. Head, T. Salmon, Comparison of two artificial tear formulations using aberrometry, Clin. Exp. Optom. 92 (2009) 206-211.
7. H. Zhu, A. Chauhan, Effect of viscosity on tear drainage and ocular residence time, Optom. Vis. Sci. 85 (2008) 715-724.
8. G. Snibson, J. Greaves, N. Soper, J. Tiffany, C. Wilson, A. Bron, Ocular surface residence times of artificial tear solutions, Cornea 11 (1992) 288-293.
9. B. Nanjawade, F. Manvi, A. Manjappa, In situ-forming hydrogels for sustained ophthalmic drug delivery, J. Control. Release 122 (2007) 119-134.
10. H. Lin, K. Sung, Carbopol/pluronic phase change solutions for ophthalmic drug delivery, J. Control. Release 69 (2000) 379-388.
11. W.P. Beetham, Filamentary Keratitis, Trans. Am. Ophthalmol. Soc. 33 (1935) 413-435.
12. J. Murube, E. Murube, Treatment of dry eye by blocking the lacrimal canaliculi, Surv. Ophthalmol. 40 (1996) 463-480.
13. P. Burgess, P. Koay, P. Clark, SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial, Cornea 27 (2008) 391-394. (Pubitemid 351591473)
14. E. Goto, Y. Yagi, M. Kaido, Y. Matsumoto, K. Konomi, K. Tsubota, Improved functional visual acuity after punctal occlusion in dry eye patients, Am. J. Ophthalmol. 135 (2003) 704-705.
15. M. Guzey, S. Karaman, A. Satici, I. Ozardali, S. Sezer, O. Bozkurt, Efficacy of Topical cyclosporine A in the treatment of severe trachomatous dry eye, Clin. Exp. Ophthalmol. 37 (2009) 541-549.
16. E. Kim, J. Choi, C. Joo, A comparison of vitamin A and cyclosporine A 0.05% eye drops for treatment of dry eye syndrome, Am. J. Ophthalmol. 147 (2009) 206-213.
17. M. Stern, R. Beuerman, R. Fox, J. Gao, A. Mircheff, S. Pflugfelder, A unified theory of the role of the ocular surface in dry eye, Adv. Exp. Med. Biol. 438 (1998) 643-651. (Pubitemid 28303801)
18. J. Borel, G. Baumann, I. Chapman, P. Donatsch, A. Fahr, E. Mueller, J. Vigouret, In vivo pharmacological effects of cyclosporin and some analogues, Adv. Pharmacol. 35 (1996) 115-246.
19. K. Kunert, A. Tisdale, M. Stern, J. Smith, I. Gipson, Analysis of topical cyclosporine A treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes, Arch. Ophthalmol. 118 (2000) 1489-1496.
20. M. Francis, M. Piredda, F. Winnik, Solubilization of poorly water soluble drugs in micelles of hydrophobically modified hydroxyproplycellulose copolymers, J. Control. Release 93 (2003) 59-68. (Pubitemid 37346268)
21. J. Sansom, K. Barnett, W. Newmann, A. Schulte-Neumann, B. Clerc, J. Jegou, V. Haas, A. Weingarten, Treatment of Keratoconjunctivits Sicca in dogs with cyclosporine ophthalmic ointment: a European clinical field trial, Vet. Rec. 137 (1995) 504-507.
22. H. Liu, Y. Wang, S. Li, Advanced delivery of ciclosporin A: present state and perspective, Expert Opin. Drug Deliv. 4 (2007) 349-358.
23. D. Tang-Liu, J. Richman, R. Weinkam, H. Takruri, Effects of four penetration enhancers on corneal permeability of drugs in vitro, J. Pharm. Sci. 83 (1994) 85-90.
24. A. Apel, C. Oh, R. Chiu, B. Saville, Y. Cheng, D. Rootman, A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy, Curr. Eye Res. 14 (1995) 659-667.
25. L. Gan, Y. Gan, C. Zhu, X. Zhang, J. Zhu, Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: In vitro and in vivo results, Int. J. Pharm. 365 (2009) 143-149.
26. C. Roberts, P. Carniglia, B. Brazzo, Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye, Cornea 26 (2007) 805-809.
27. M. Doane, Blinking and the mechanics of the lacrimal drainage system, Ophthalmology 88 (1981) 844-851. (Pubitemid 11039474)
28. Cohan et al, Ophthalmic insert and method for sustained release of medication to the eye, US patent no.6,196,993.
29. Prescott et al, Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same, US Patent 7117870.
30. Borgia et al, Punctal plugs for the delivery of active agents, US patent.
31. G. Ismailos, C. Peppas, J. Dressman, P. Macheras, Unusual solubility behavior of cyclosporine A in aqueous media, J. Pharm. Pharmacol. 43 (1991) 287-289.
32. C. Gupta, A. Chauhan, Drug transport in HEMA conjunctival inserts containing precipitated drug particles, J. Coll. Interf. Sci. 347 (2010) 31-42.
33. H. Zhu, A. Chauhan, A Mathematical model for tear drainage through the canaliculi, Curr. Eye Res. 30 (2005) 621-630.
34. S. Mishima, A. Gasset, S.J. Klyce, J. Baum, Determination of tear volume and tear flow, Invest. Ophthalmol. 5 (1966) 264-276.
35. R. Schoenwald, Ocular drug delivery, pharmacokinetic considerations, Clin. Pharmacokinet. 18 (1990) 255-269. (Pubitemid 20134535)
36. A. Czogalla, Oral cyclosporine A - the current picture of its liposomal and other delivery systems, Cell. Mol. Biol. Lett. 14 (2009) 139-152.
37. S. Hasany, P. Basu, Changes of MK Medium during storage of human cornea, B. J. Ophthalmol. 71 (1987) 477-483.
38. http://www.fda.gov/ohrms/dockets/ac/99/transcpt/3539t1a.pdf.
39. D. Korb, J. Craig, M. Doughty, J. Guillon, A. Tomlinson, G. Smith, Structure and function of the preocular tear film, The tear film:structure, function and clinical examination, Butterworth-Heinemann, Oxform, Boston, 2002, pp. 37-39.